NEUROGENE INC (NGNE)
(Delayed Data from NSDQ)
$21.22 USD
-0.24 (-1.12%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $21.28 +0.06 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Neurogene Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NGNE 21.22 -0.24(-1.12%)
Will NGNE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NGNE based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NGNE
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NGNE Stock News
NGNE Crosses Above Key Moving Average Level
Commit To Buy Neurogene At $15, Earn 27.3% Using Options
Analysts Are Bullish on Top Healthcare Stocks: Neurogene (NGNE), Cogent Biosciences (COGT)
12 Health Care Stocks Moving In Friday's After-Market Session